share_log

BeiGene (NASDAQ:BGNE) Is Using Debt Safely

BeiGene (NASDAQ:BGNE) Is Using Debt Safely

百濟神州(納斯達克股票代碼:BGNE)正在安全地使用債務
Simply Wall St ·  04/27 00:41

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it might be obvious that you need to consider debt, when you think about how risky any given stock is, because too much debt can sink a company. As with many other companies BeiGene, Ltd. (NASDAQ:BGNE) makes use of debt. But the real question is whether this debt is making the company risky.

由伯克希爾·哈撒韋公司的查理·芒格支持的外部基金經理李露對此毫不掩飾,他說:“最大的投資風險不是價格的波動,而是你是否會遭受永久的資本損失。”因此,很明顯,當你考慮任何給定股票的風險時,你需要考慮債務,因爲過多的債務會使公司陷入困境。與許多其他公司一樣,百濟神州有限公司(納斯達克股票代碼:BGNE)也使用債務。但真正的問題是這筆債務是否使公司面臨風險。

What Risk Does Debt Bring?

債務會帶來什麼風險?

Generally speaking, debt only becomes a real problem when a company can't easily pay it off, either by raising capital or with its own cash flow. If things get really bad, the lenders can take control of the business. While that is not too common, we often do see indebted companies permanently diluting shareholders because lenders force them to raise capital at a distressed price. Having said that, the most common situation is where a company manages its debt reasonably well - and to its own advantage. When we examine debt levels, we first consider both cash and debt levels, together.

一般而言,只有當公司無法通過籌集資金或利用自己的現金流輕鬆償還債務時,債務才會成爲真正的問題。如果情況變得非常糟糕,貸款人可以控制業務。儘管這種情況並不常見,但我們經常會看到負債公司永久稀釋股東,因爲貸款人強迫他們以不利的價格籌集資金。話雖如此,最常見的情況是公司合理地管理債務,而且是爲了自己的利益。當我們檢查債務水平時,我們首先要同時考慮現金和債務水平。

What Is BeiGene's Net Debt?

百濟神州的淨負債是多少?

As you can see below, at the end of December 2023, BeiGene had US$886.0m of debt, up from US$538.1m a year ago. Click the image for more detail. However, it does have US$3.17b in cash offsetting this, leading to net cash of US$2.29b.

如下所示,截至2023年12月底,百濟神州的債務爲8.86億美元,高於去年同期的5.381億美元。點擊圖片查看更多細節。但是,它確實有31.7億美元的現金抵消了這一點,淨現金爲22.9億美元。

debt-equity-history-analysis
NasdaqGS:BGNE Debt to Equity History April 26th 2024
NASDAQGS: BGNE 債券與股本比率歷史記錄 2024 年 4 月 26 日

How Strong Is BeiGene's Balance Sheet?

百濟神州的資產負債表有多強?

According to the last reported balance sheet, BeiGene had liabilities of US$1.81b due within 12 months, and liabilities of US$457.8m due beyond 12 months. On the other hand, it had cash of US$3.17b and US$395.9m worth of receivables due within a year. So it can boast US$1.30b more liquid assets than total liabilities.

根據上次報告的資產負債表,百濟神州的負債爲18.1億美元,12個月後到期的負債爲4.578億美元。另一方面,它有31.7億美元的現金和價值3.959億美元的應收賬款將在一年內到期。因此,它擁有的流動資產可以多出13.0億美元 負債。

This surplus suggests that BeiGene has a conservative balance sheet, and could probably eliminate its debt without much difficulty. Simply put, the fact that BeiGene has more cash than debt is arguably a good indication that it can manage its debt safely. There's no doubt that we learn most about debt from the balance sheet. But ultimately the future profitability of the business will decide if BeiGene can strengthen its balance sheet over time. So if you're focused on the future you can check out this free report showing analyst profit forecasts.

這種盈餘表明百濟神州的資產負債表比較保守,很可能可以毫不費力地消除債務。簡而言之,百濟神州的現金多於債務這一事實可以說是一個很好的跡象,表明它可以安全地管理債務。毫無疑問,我們從資產負債表中學到的關於債務的知識最多。但最終,該業務的未來盈利能力將決定百濟神州能否隨着時間的推移加強其資產負債表。因此,如果您專注於未來,可以查看這份顯示分析師利潤預測的免費報告。

Over 12 months, BeiGene reported revenue of US$2.5b, which is a gain of 74%, although it did not report any earnings before interest and tax. With any luck the company will be able to grow its way to profitability.

在過去的12個月中,百濟神州公佈的收入爲25億美元,增長了74%,儘管它沒有報告任何利息和稅前收益。運氣好的話,該公司將能夠實現盈利。

So How Risky Is BeiGene?

那麼百濟神州有多危險?

Statistically speaking companies that lose money are riskier than those that make money. And in the last year BeiGene had an earnings before interest and tax (EBIT) loss, truth be told. And over the same period it saw negative free cash outflow of US$1.8b and booked a US$882m accounting loss. However, it has net cash of US$2.29b, so it has a bit of time before it will need more capital. With very solid revenue growth in the last year, BeiGene may be on a path to profitability. By investing before those profits, shareholders take on more risk in the hope of bigger rewards. The balance sheet is clearly the area to focus on when you are analysing debt. But ultimately, every company can contain risks that exist outside of the balance sheet. To that end, you should be aware of the 1 warning sign we've spotted with BeiGene .

從統計學上講,虧損的公司比賺錢的公司風險更大。說實話,去年百濟神州出現了息稅前收益(EBIT)虧損。同期,它的自由現金流出爲負18億美元,會計虧損爲8.82億美元。但是,它的淨現金爲22.9億美元,因此在需要更多資金之前還有一段時間。百濟神州去年收入增長非常穩健,可能正走上盈利之路。通過在這些利潤之前進行投資,股東會承擔更大的風險,希望獲得更大的回報。資產負債表顯然是分析債務時需要關注的領域。但歸根結底,每家公司都可以控制資產負債表之外存在的風險。爲此,你應該注意我們在百濟神州發現的1個警告信號。

Of course, if you're the type of investor who prefers buying stocks without the burden of debt, then don't hesitate to discover our exclusive list of net cash growth stocks, today.

當然,如果你是那種喜歡在沒有債務負擔的情況下購買股票的投資者,那麼請立即查看我們的獨家淨現金增長股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論